Sponsor pipeline

Guang'anmen Hospital of China Academy of Chinese Medical Sciences clinical trial pipeline

Get alerts when Guang'anmen Hospital of China Academy of Chinese Medical Sciences's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  1. Minor

    TCMWINE · Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy · High-risk of ESRD

    Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting

    Guang'anmen Hospital of China Academy of Chinese Medical SciencesPhase 2/3 NCT03418779 Registry history of NCT03418779 on ClinicalTrials.gov (opens the registry)

    Changed

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-13 NCT07870564 the Effect and Mechanism of Percutaneous Auricular Electrical Stimulation in Preventing… Not Yet Recruiting

Active trials by phase

Phase 2
1
Phase 4
2
Not charted: 23 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 15

Get alerts when Guang'anmen Hospital of China Academy of Chinese Medical Sciences's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free